JW Pharmaceutical Buys Group's Venture Arm Solidus for 30.7 Billion Won
JW Pharmaceutical is paying 30.7 billion won ($22 million) for a 100% stake in Solidus Investment, relocating the group's VC arm after JW Holdings lost holding company status in June.